adjane.comCrawled Oct 24, 2026
The platform uses a genetically optimized *Neisseria meningitidis* strain to produce outer membrane vesicles, enabling safe, high-yield vaccines with multivalent antigen display.
Our Programs PLATFORM • PROGRAM OVERVIEW AdJane Biosciences is developing its platform further, by means of multiple programs across viral and bacterial indications to validate its breadth. discovery pre-clinical phase I phase II phase III COVID-19 COVID-19 PHASE I Our COVID-19 program was based on intranasal co-administration of our Nm-nOMV platform with SARS-CoV-2 spike protein. […]
Whitepaper AdJane – Boosting mRNA: Mucosal Immunity and a Platform beyond it
Whitepaper AdJane - Boosting mRNA: Mucosal Immunity and a Platform beyond it
July-August 2026 edition of MedNous, a publication of Evernow Publishing Ltd.
The Nm-nOMV platform is described in peer-reviewed papers, including a 2023 study on intranasal vaccine administration.
CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea.
Whitepaper AdJane – Boosting mRNA: Mucosal Immunity and a Platform
Anita Gashi leads AdJane as CEO, commercializing a vaccine platform from Dutch public research and building partnerships in pharmaceutical and vaccine R&D.
Eric Claassen is an immunologist and entrepreneur, formerly Professor of Immunology and Valorisation at Erasmus MC and the first Biopartner Professor of Entrepreneurship in Life Sciences.
Gina van der Werf is CEO of FDI, an entrepreneurial group turning research into ventures, having led the company since its 2017 formation from TNO Bedrijven.
Hanneke Schuitemaker serves as Chief Scientific Officer at Valneva and Professor of Virology at Amsterdam UMC, with expertise in virology and vaccine development from academic and industrial roles.
Contact For partnership inquiries: partnering@adjane.com Or use the contact form below.
AdJane Biosciences develops scalable mucosal vaccines inducing systemic and mucosal immunity, addressing the gap between vaccine administration routes and infection sites.
